Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2013 Q1- Text added to 2013 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
acidity, appoint, aspirated, aspiration, asthma, bacteria, bear, behalf, beneficial, binding, borne, Boushey, budget, charter, compound, contemplated, customarily, diagnostic, digit, discomfort, disseminated, dysfunction, elderly, emphysema, emptying, epidemiological, esophageal, Francisco, freely, gastric, globally, half, hampered, Homer, idiopathic, iii, implicated, impossible, inconvenience, indirectly, insensitivity, investigate, IV, joint, Marketplace, microaspiration, molecule, morbidity, mycobacteria, namedPulmaquin, NASDAQ, NIH, nominating, older, Oregon, oropharynx, paradigm, pathogenic, percent, permit, pneumonia, PNTM, preemptive, proceed, Professor, prohibited, reconstituted, recurrent, reflux, repeatedly, representation, role, Rule, salable, San, SBIR, scleroderma, silent, simple, simultaneously, soliciting, standstill, subclinical, successor, supply, supplying, tracheobronchial, tract, transplantation, tree, UCSF, voted, voting, worsening
Removed:
capacity, continued, launch, lender, offering, Overview, PBS, Pharma, repay, utilizing
Valuein 2013 Q1 filing- Value in 2013 Q2 filing
Original filings
Filing view